DHARMAJ CROP GUARD LIMITED

DHARMAJ CROP GUARD LIMITED

‍

Samiksha: Quarterly Earnings Deep-Dive Analysis – Q2 FY2026 (July–September 2025)
Extracting Alpha out of Quarterly Results
Date: November 18, 2025

‍

EXECUTIVE SUMMARY DASHBOARD

Execution Score (0–100): 62 / 100
Management Credibility Score: 68 / 100

Quarter Surprise Factor

• MISS on Profitability; BEAT on Revenue

Revenue Variance

• +11.5% YoY (₹347.3 Cr vs ₹311.3 Cr) → Beat expectations

EBITDA Variance

• -7.5% YoY (₹31.9 Cr vs ₹34.5 Cr)
• Margin: 9.17% vs 11.08% → Significant Miss

PAT Variance

• -17.5% YoY (₹17.35 Cr vs ₹21.03 Cr) → Major Disappointment

Investment Thesis Impact

• WEAKENED – Margin compression concerns overshadow revenue growth

Key Takeaway
Q2 reveals a two-speed business: Formulations struggling with pricing power; Technical/AI segment showing promise but not enough to offset overall margin pressure.

Quarter Grade: C+
(Revenue growth commendable; profitability collapse concerning)

‍

1. STRATEGIC EXECUTION TRACKER

Promise vs Performance Matrix

Unit 2 (Sayakha) Ramp-Up

• Original Timeline: Q1 FY26 gradual ramp-up; H1 target ₹118 Cr sales
• Current Status: ✅ ACHIEVED – H1 sales ₹118 Cr; Q2 contribution +12% QoQ
• Explanation: Production activities gradually ramping
• Credibility Score: ⭐⭐⭐⭐⭐ (100/100)

FY26 Revenue Growth (20–25%)

• Guided: Q4 FY25 earnings call
• Current Status: ⚠️ ON TRACK – H1 revenue +26.1% YoY; Q2 +11.5%
• Explanation: Deceleration vs Q1 (44% → 11.5%), full-year target achievable
• Credibility Score: ⭐⭐⭐⭐ (85/100)

EBITDA Margin Sustainability (13–14%)

• Guided: Q1 FY26 – 14% margins sustainable
• Current Status: ❌ MISSED – Q2 margin 9.17% vs Q1 13.8%
• Explanation: Sharp compression due to formulation pricing pressure + Unit 2 OpEx
• Credibility Score: ⭐⭐ (40/100)

Export Recovery (Post-FY25 Slowdown)

• Guided: Q1 FY26 – strong rebound
• Current Status: ⚠️ MIXED – Q1 recovery; Q2 data not disclosed
• Explanation: Management silent on Q2 export performance (red flag)
• Credibility Score: ⭐⭐⭐ (60/100)

Brazil Subsidiary Incorporation

• Announced: Q2 FY26
• Current Status: ✅ IN PROGRESS – Board approved; incorporation initiated
• Explanation: Regulatory approvals pending; expected completion Q4 FY26
• Credibility Score: ⭐⭐⭐⭐ (80/100)

New Product Registrations

• Ongoing: 11 new technical registrations filed Q2
• Current Status: ✅ ON TRACK – 18 received, 30 awaited
• Explanation: Healthy pipeline; 4 new B2C products launched Q2
• Credibility Score: ⭐⭐⭐⭐ (85/100)

Formulation Volume Growth (Kharif Season)

• Guided: Strong start; robust growth expected
• Current Status: ⚠️ UNDERPERFORMED – Volume growth offset by lower realizations
• Explanation: Weak pricing power; agrochemical price correction Apr–Aug
• Credibility Score: ⭐⭐⭐ (55/100)

‍

Management Credibility Score: 68 / 100

Historical Guidance Accuracy (Last 8 Quarters)

• Revenue Growth: 6/8 met (75%)
• Margin Expansion: 3/8 met (37.5%) – Weak spot
• Strategic Milestones: 7/8 met (87.5%)
• Capex Deployment: 7/8 met (87.5%)

Assessment
Strong operational execution (Unit 2, registrations, Brazil expansion) but weak margin forecasting in volatile agrochemical pricing environment. Q2 margin miss materially damages credibility.

‍

Resource Allocation Efficiency

Capital Deployment (H1 FY26)

• Unit 2 capex largely complete; commercialization phase
• Brazil subsidiary minimal initial investment
• Total assets increased to ₹955.9 Cr (Sept 2025) from ₹733.4 Cr (Mar 2025)
• R&D: 11 new technical registrations filed Q2

Human Resources

• Unit 2 workforce ramp-up increased OpEx
• No major leadership changes

Strategic Pivot
Shift from “volume growth at any cost” to “selective margin-accretive growth”

Efficiency Rating: 7 / 10

‍

‍

2. EARNINGS QUALITY & SUSTAINABILITY ASSESSMENT

Core Earnings Reconciliation

• Revenue from Operations: ₹347.26 Cr
• Total Expenses: ₹315.81 Cr
• EBITDA: ₹31.86 Cr
• EBITDA Margin: 9.17%
• PAT: ₹17.35 Cr
• PAT Margin: 5.00%
• EPS: ₹5.13

One-Time Items Identified

1. Unit 2 ramp-up costs: ₹2–3 Cr
2. Other operating income decline: -₹2.61 Cr YoY

Adjusted Core PAT: ₹19–20 Cr
(Core decline 5–10% YoY vs reported 17.5%)

Earnings Quality Score: 70 / 100

‍

Cash Conversion & Working Capital

• Total assets up ₹222 Cr in 6 months
• Likely drivers: inventory buildup, Unit 2 stocking, receivables
• Concern: Assets +30% vs revenue +26%

Quality of Earnings Score: 65 / 100

‍

Margin Sustainability

Estimated Margin Trend

• Q2 FY25 EBITDA: 11.08%
• Q1 FY26 EBITDA: 13.80%
• Q2 FY26 EBITDA: 9.17%

Margin Quality Score: 55 / 100

‍

Revenue Quality

• 100% organic growth
• Dealer network: 4,362+ (low concentration)
• Recurring revenue: 90–95%

Revenue Quality Score: 72 / 100

‍

‍

3. FORWARD-LOOKING STRATEGIC INTELLIGENCE

Management Sentiment Score: 5.5 / 10
(Cautiously Neutral)

Key Signals

• Defensive tone on margins
• Strong emphasis on Unit 2
• Silence on exports (red flag)

‍

‍

4. INDUSTRY CROSS-REFERENCE ANALYSIS

Peer Comparison (Q2 FY26)

• PI Industries: EBITDA margin 28.9%
• UPL: EBITDA margin 18.3%
• Dharmaj: EBITDA margin 9.17%

Conclusion
Mid-tier margin pressure appears structural, not cyclical.

‍

‍

5. UNIQUE DIFFERENTIATION ELEMENTS

• Unit 2 capacity optionality
• Brazil subsidiary (Latin America gateway)
• Registration pipeline as hidden asset

‍

‍

6. INDUSTRY-SPECIFIC MODULE: AGROCHEMICALS

• Combined optimal capacity: ₹1,400–1,800 Cr
• Unit 2 ramp-up critical for margin recovery
• Strategic shift toward AI / Technical products

‍

‍

7. RISK-REWARD ASSESSMENT

Bull Case (35%)

• Target: ₹880–980

Base Case (50%)

• Target: ₹620

Bear Case (15%)

• Target: ₹286–351

‍

‍

8. CATALYST TIMELINE & WATCH ITEMS

Key Near-Term Trigger:

• Q3 FY26 margin recovery above 10.5%

‍

‍

9. INVESTMENT RECOMMENDATION

PRIMARY RECOMMENDATION: HOLD
(Upgrade to BUY on Q3 execution confirmation)

• Target Price: ₹620
• Current Price: ₹480
• Upside: 29% (18–24 months)
• Risk Rating: MEDIUM-HIGH (6.55 / 10)

‍

‍

FINAL INVESTMENT THESIS SUMMARY

Dharmaj Crop Guard presents undervalued optionality via Unit 2, Brazil subsidiary, and registration pipeline, but near-term execution uncertainty warrants a HOLD stance pending Q3 FY26 confirmation.

‍

‍

Compliance & Disclosures

© 2025 Oorjita FinAI Services. All Rights Reserved.

www.oorjita.ai is not operated by a broker, dealer, or registered investment adviser. No information on this site constitutes investment advice or a recommendation to buy or sell securities. Information is not guaranteed for accuracy or completeness. Oorjita FinAI Services shall not be liable for any losses arising from use of this content. Past performance is a poor indicator of future performance.

‍